Keyphrases
ST-elevation Myocardial Infarction (STEMI)
100%
Primary Percutaneous Coronary Intervention
51%
Percutaneous Coronary Intervention
28%
Acute Myocardial Infarction
21%
Granulocyte Colony-stimulating Factor (G-CSF)
16%
Infarct Size
16%
Stem Cells
16%
Hazard Ratio
15%
Clinical Outcomes
14%
Mesenchymal Stromal Cells
13%
Intramyocardial Injection
13%
Confidence Interval
13%
Chronic Ischemic Heart Disease
12%
Revascularization
12%
Stable Coronary Artery Disease
12%
Myocardial Infarction
11%
Adipose-derived Stromal Cells
11%
Complete Revascularization
11%
Primary PCI
11%
Myocardial Infarction Patients
10%
Left Ventricular Function
10%
Left Ventricular Ejection Fraction
10%
Small Vessel Disease
10%
Acute Coronary Syndrome
9%
Refractory Angina
9%
Stent Implantation
9%
Fractional Flow Reserve
9%
Optical Coherence Tomography
9%
Cardiac Magnetic Resonance
9%
All-cause Mortality
9%
Human Mesenchymal Stem Cells (hMSCs)
9%
Coronary Angiography
8%
Ischemic Heart Disease
8%
Heart Failure
8%
Myocardial Infarction Disease
8%
Cell Treatment
8%
Final Infarct Size
7%
Culprit Lesion
7%
Randomized Placebo-controlled Trial
7%
Vascular Endothelial Growth Factor
7%
Infarct-related Artery
7%
Exenatide
7%
Placebo
7%
Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS)
7%
Randomized Controlled Trial
7%
Intramyocardial
7%
3-year Follow-up
6%
Bare Metal Stent
6%
Myocardial Injury
6%
Drug-eluting Stent
6%
Medicine and Dentistry
ST Segment Elevation Myocardial Infarction
75%
Primary Percutaneous Coronary Intervention
38%
Percutaneous Coronary Intervention
38%
Mesenchymal Stem Cell
26%
Infarction
20%
Revascularization
18%
Coronary Artery Disease
18%
Myocardial Infarction
16%
Ischemic Heart Disease
16%
Acute Heart Infarction
16%
Stem Cell
15%
ST Elevation
15%
Placebo
15%
Coronary Angiography
14%
Heart Muscle Ischemia
13%
Granulocyte Colony Stimulating Factor
13%
Heart Failure
13%
Acute Coronary Syndrome
12%
Disease
12%
Hazard Ratio
12%
Adipose Tissue
11%
Angina pectoris
10%
Cardiac Magnetic Resonance Imaging
9%
Symptom
9%
Heart Left Ventricle Ejection Fraction
9%
Optical Coherence Tomography
9%
Drug-Eluting Stent
8%
Artery
8%
Fractional Flow Reserve
7%
Stromal Cell
7%
Randomized Controlled Trial
7%
Heart Left Ventricle Function
7%
Heart Muscle Injury
6%
Electrocardiogram
6%
Myocardium
5%
Long Term Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
ST Segment Elevation Myocardial Infarction
83%
Infarction
32%
Ischemic Heart Disease
24%
Coronary Artery Disease
24%
Heart Failure
16%
Heart Infarction
16%
Acute Heart Infarction
14%
Placebo
13%
Acute Coronary Syndrome
11%
Symptom
10%
Disease
10%
Heart Muscle Ischemia
9%
Granulocyte Colony Stimulating Factor
9%
Heart Muscle Injury
8%
Exendin 4
7%
Vasculotropin
7%
All Cause Mortality
6%
Clopidogrel
6%
Cardiovascular Disease
6%
Randomized Clinical Trial
6%
Clinical Trial
5%
Stenosis
5%
Bleeding
5%
Ischemia
5%
